Amgen Inc (AMGN) develops, manufactures and delivers innovative human ... Out of all the analysts who have rated the stock in the past 3 months, TipRanks shows that 61.5% are bullish on the shares and 38.5% are neutral. None of the …
Rating reiterations for Jan. 25 from Briefing.com: Company Symbol Brokerage Firm Reiterations Alaska Air ALK UBS Neutral Amgen AMGN Lehman Brothers Overweight Ariba ARBA Roth Capital Buy ArthroCare ARTC SMH Capital Buy …
Large-capitalization biotechnology stocks as represented by the iShares Nasdaq Biotechnology Index (ETF) (NASDAQ:IBB) lifted on Thursday on the back of comments from the Independent Payment Advisory Board said that …
In after-hours, the stock rose another 12.54% to $6.82. Shares of CytomX Therapeutics Inc. (CTMX) were up 35% in extended trading on Tuesday, following a strategic collaboration with Amgen (AMGN). Under the terms of the …
Lucas Energy (NYSE: LEI) 22.3% LOWER; files prospectus related to 6 million common shares for selling …
AMGN) has received a CRL [complete response letter] in relation to Parsabiv, a calcimimetic under review by the FDA for secondary hyperthyroidism. This unexpected development is likely to have only a “minimal material impact” on the …
Amgen Inc. (AMGN) Amgen, which is scheduled to release earnings after ... But while the market gained +18.8% from 2016 - Q1 2017, our top stock-picking screens have returned +157.0%, +128.0%, +97.8%, +94.7%, and +90.2% …
AMGN closed Friday's trading at $135.40, up 0.13%. There has been much speculation about whether Cempra Inc.'s (CEMP) investigational drug Solithromycin will clear the penultimate regulatory hurdle of winning the FDA panel …
co will make upfront payment of $40 million and purchase $20 million of cytomx common stock.CytomX will be eligible to receive up to $455 million in development, regulatory and commercial milestones for EGFR program.CytomX to be able …
These revelations caused Amgen Inc (NASDAQ: AMGN) stock price to decline. Those who purchased shares of Amgen …